Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline.


Clinical Trial Description

The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline. These complications include partial or complete obstruction, infection of the central line, and/or the onset of heparin induced thrombocytopenia. ;


Study Design


Related Conditions & MeSH terms

  • Catheter; Complications (Indwelling Catheter)
  • Obstruction; Catheter, Infusion Catheter (Vascular)

NCT number NCT02354118
Study type Interventional
Source TriHealth Inc.
Contact
Status Completed
Phase N/A
Start date January 2013
Completion date December 17, 2021

See also
  Status Clinical Trial Phase
Terminated NCT02923830 - Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes Phase 4